NanoValent Pharmaceuticals, Inc.

@Nanovalent_

NanoValent is a pharmaceutical company developing a new nano-particle based (TNS) Targeted NanoSpheres technology to create & develop novel cancer therapies.

Vrijeme pridruživanja: siječanj 2020.

Tweetovi

Blokirali ste korisnika/cu @Nanovalent_

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Nanovalent_

  1. Nanovalent: Animal data suggest superior efficacy and improved tolerability to approved chemotherapy

    Poništi
  2. The Survival and Incidence Rate of Ewing Sarcoma; a National Population-based Study in Iran (2008-2015)

    Poništi
  3. Poništi
  4. Nanovalent: Animal data suggest superior efficacy and improved tolerability to approved chemotherapy

    Poništi
  5. The Survival and Incidence Rate of Ewing Sarcoma; a National Population-based Study in Iran (2008-2015)

    Poništi
  6. Poništi
  7. Repositioning existing chemotherapeutics by optimizing delivery of emerging small molecule, RNA, or biologic candidates.

    Poništi
  8. Repositioning existing chemotherapeutics by optimizing delivery of emerging small molecule, RNA, or biologic candidates.

    Poništi
  9. Poništi
  10. Poništi
  11. Ewing's Sarcoma Treatment Market Research Report By Major Players, Trends And Challenges in Pharmaceuticals, Biotechnology & Life Sciences,Pharmaceuticals sector To 2023

    Poništi
  12. Poništi
  13. Ewing's Sarcoma Treatment Market Research Report By Major Players, Trends And Challenges in Pharmaceuticals, Biotechnology & Life Sciences,Pharmaceuticals sector To 2023

    Poništi
  14. Poništi
  15. NanoValent's platform is more than just an improved nanosphere liposome delivery vehicle

    Poništi
  16. Poništi
  17. NanoValent's platform is more than just an improved nanosphere liposome delivery vehicle

    Poništi
  18. Repositioning existing chemotherapeutics by optimizing delivery of emerging small molecule, RNA, or biologic candidates.

    Poništi
  19. Poništi
  20. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·